Skip to Content

Lattice Biologics Ltd LBLTF

Morningstar Rating
$0.00 0.00 (0.00%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

LBLTF is trading within a range we consider fairly valued.
Price
$0.00
Fair Value
$9.63
Uncertainty
Extreme
1-Star Price
$6.27
5-Star Price
$9.76
Economic Moat
Mjmrq
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if LBLTF is a good fit for your portfolio.

Trading Information

Previous Close Price
$0.00
Day Range
$0.000.00
52-Week Range
$0.000.00
Bid/Ask
$0.01 / $0.45
Market Cap
$128.22
Volume/Avg
1,000 / 4,250

Key Statistics

Price/Earnings (Normalized)
Price/Sales
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Lattice Biologics Ltd is a biologic product manufacturing company. It manufactures and markets biologic products to domestic and international markets. The products of the company include ADM dermis, DBM Putty, Bone scaffold, and Others, of which key revenue is derived from Bone scaffold. The biologic products are used in various applications such as enhancing fusion in spine surgery, enhancing breast reconstruction post mastectomy for breast cancer patients, sports medicine applications, promotion of bone in foot and ankle surgery, promotion of skull healing following neurosurgery, and subchondral bone defect repair in knee and other joint surgeries. The company generates its revenue from operations principally carried in the United States of America.
Sector
Healthcare
Industry
Medical Devices
Stock Style Box
Small Value
Total Number of Employees

Valuation

Metric
LBLTF
Price/Earnings (Normalized)
Price/Book Value
Price/Sales
Price/Cash Flow
Price/Earnings
LBLTF

Financial Strength

Metric
LBLTF
Quick Ratio
Current Ratio
Interest Coverage
−0.59
Quick Ratio
LBLTF

Profitability

Metric
LBLTF
Return on Assets (Normalized)
−49.18%
Return on Equity (Normalized)
Return on Invested Capital (Normalized)
Return on Assets
LBLTF
See how this stock stacks up to its competitors with Morningstar Investor

Medical Devices Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Economic Moat
Market Cap
ABT
Abbott LaboratoriesHqslrs$208.3 Bil
SYK
Stryker CorpDydp$133.8 Bil
MDT
Medtronic PLCKtrf$110.8 Bil
BSX
Boston Scientific CorpRnlxf$98.3 Bil
EW
Edwards Lifesciences CorpTznbxlj$51.7 Bil
DXCM
DexCom IncVpvqb$44.0 Bil
ZBH
Zimmer Biomet Holdings IncZyzwh$25.5 Bil
ALGN
Align Technology IncRlrzt$23.2 Bil
PHG
Koninklijke Philips NV ADRGzsxqn$18.2 Bil
SNN
Smith & Nephew PLC ADRWvxjdw$11.6 Bil

Sponsor Center